Non-clinical safety studies using minipigs
Scantox, which we represent, is a leading European CRO with over 40 years of experience in non-clinical safety testing of pharmaceuticals. They undertake toxicity testing using a variety of small and large animals, and are particularly proud of their world-class track record in toxicity testing using miniature pigs.
Please feel free to contact the Lunapath Toxicologic Pathology Laboratory for any inquiries or requests for testing with Scantox.
About Scantox
As a contract research organization (CRO), Scantox supports a wide range of drug development activities, from lead compound optimization through in vitro and in vivo efficacy test models, formulation development, regulatory toxicity testing, to drug manufacturing for Phase I and II clinical trials. With our trusted collaboration based on our advanced technical capabilities and over 40 years of scientific experience, we are able to provide a one-stop service for your development projects.
In particular, we are one of the world's leading CROs in the field of pharmaceutical safety testing using miniature pigs, and we also have extensive experience in efficacy testing and genotoxicity testing in the fields of neurological disorders and rare diseases.
Facility Overview
The Scantox Group is headquartered in Ejby, Lille Skensved, approximately 30 minutes from Copenhagen, and has further subsidiaries in Austria, Sweden and the UK.
Preclinical trials for neurodegenerative and rare diseases
In vitro:
Alzheimer's disease model, Parkinson's disease model, neuroinflammation, lesion induction model
In vivo:
Alzheimer's, Parkinson's disease, ALS, Huntington's disease, MS, NPC1, MPS, lipid storage diseases such as Gaucher, Alport syndrome, dyslipidemia, psychosis, anxiety, schizophrenia, autism
-
-
APPSL
-
APPSL x hQC
-
5xFAD
-
Tg2576
-
-
-
TMHT
-
hTau
-
PS19
-
Preclinical trials for neurodegenerative and rare diseases
In vitro:
Alzheimer's disease model, Parkinson's disease model, neuroinflammation, lesion induction model
In vivo:
Alzheimer's, Parkinson's disease, ALS, Huntington's disease, MS, NPC1, MPS, lipid storage diseases such as Gaucher, Alport syndrome, dyslipidemia, psychosis, anxiety, schizophrenia, autism
Facility Overview
The Scantox Group is headquartered in Ejby, Lille Skensved, approximately 30 minutes from Copenhagen, and has further subsidiaries in Austria, Sweden and the UK.
Scantox A/S
Hestehavevej 36A, Ejby
4623 Lille Skensved
Denmark
Tel: +45 5686 1500
Regulatory Toxicity Studies
General Toxicology Testing (Non-GLP/GLP):
Single-dose toxicity test/Repeated-dose toxicity test
Safety pharmacology studies:
Cardiovascular system (dog, minipig), CNS, respiratory system (rat)
Reproductive and developmental toxicity tests (minipigs, rats, rabbits)
Pharmacokinetic studies
Juvenile animal testing (mini pigs)
SEND
Scantox Neuro
Parkring 12
8074 Grambach, Austria
+43 (0) 316 258111
Preclinical trials for neurodegenerative and rare diseases
In vitro:
Alzheimer's disease model, Parkinson's disease model, neuroinflammation, lesion induction model
In vivo:
Alzheimer's, Parkinson's disease, ALS, Huntington's disease, MS, NPC1, MPS, lipid storage diseases such as Gaucher, Alport syndrome, dyslipidemia, psychosis, anxiety, schizophrenia, autism